Risks of serious liver injury, herpes meningoencephalitis with Gilenya

    This is a preview of subscription content, access via your institution.

    Reference

    1. Medicines and Healthcare products Regulatory Agency (UK). Fingolimod (Gilenya): updated advice about the risks of serious liver injury and herpes meningoencephalitis. Internet Document : 7 Jan 2021. Available from: URL: https://www.gov.uk/drug-safety-update/fingolimod-gilenyav-updated-advice-about-the-risks-of-serious-liver-injury-and-herpes-meningoencephalitis

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Risks of serious liver injury, herpes meningoencephalitis with Gilenya. Reactions Weekly 1839, 9 (2021). https://doi.org/10.1007/s40278-021-89847-8

    Download citation